The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, vol.53, issue.5, p.110714, 1999. ,
DOI : 10.1212/WNL.53.5.1107
Aquaporin 4 and neuromyelitis optica, The Lancet Neurology, vol.11, issue.6, p.53544, 2012. ,
DOI : 10.1016/S1474-4422(12)70133-3
Neuromyelitis optica: clinical features, immunopathogenesis and treatment, Clinical & Experimental Immunology, vol.260, issue.2, p.14964, 2014. ,
DOI : 10.1111/cei.12271
Demographic and clinical features of neuromyelitis optica: A review, Multiple Sclerosis Journal, vol.21, issue.7, p.84553, 2015. ,
DOI : 10.1212/WNL.0b013e3181ea9f15
Neuromyelitis optica in France: A multicenter study of 125 patients, Neurology, vol.74, issue.9, p.73642, 2010. ,
DOI : 10.1212/WNL.0b013e3181d31e35
The spectrum of neuromyelitis optica, The Lancet Neurology, vol.6, issue.9, p.80515, 2007. ,
DOI : 10.1016/S1474-4422(07)70216-8
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, The Journal of Experimental Medicine, vol.43, issue.4, p.4737, 2005. ,
DOI : 10.1523/JNEUROSCI.1485-04.2004
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre, Brain, vol.130, issue.5, p.123543, 2007. ,
DOI : 10.1093/brain/awm062
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis, Brain, vol.130, issue.5, p.122434, 2007. ,
DOI : 10.1093/brain/awm047
Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications, Neurology, vol.76, issue.14, p.122937, 2011. ,
DOI : 10.1212/WNL.0b013e318214332c
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients, Journal of Neuroinflammation, vol.76, issue.Pt 1, p.14, 2012. ,
DOI : 10.1186/1742-2094-9-14
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance, Nature Reviews Neurology, vol.55, issue.7, p.38392, 2010. ,
DOI : 10.1038/nrneurol.2010.72
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies, The International Journal of Biochemistry & Cell Biology, vol.44, issue.9, p.151930, 2012. ,
DOI : 10.1016/j.biocel.2012.06.013
Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review, Journal of the Neurological Sciences, vol.355, issue.1-2, p.717, 2015. ,
DOI : 10.1016/j.jns.2015.05.034
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays, Journal of Biological Chemistry, vol.287, issue.17, p.1382939, 2012. ,
DOI : 10.1074/jbc.M112.344325
Autoimmune T cell responses in the central nervous system, Nature Reviews Immunology, vol.30, issue.6, p.393407, 2009. ,
DOI : 10.1038/nri2550
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6, Multiple Sclerosis Journal, vol.115, issue.12, p.144352, 2010. ,
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders, Journal of Neuroimmunology, vol.293, p.1004, 2016. ,
DOI : 10.1016/j.jneuroim.2016.03.004
Th17 cells in neuromyelitis optica spectrum disorder: a review, International Journal of Neuroscience, vol.17, issue.1, 2016. ,
DOI : 10.2967/jnumed.111.102608
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica, Brain Pathology, vol.27, issue.1, p.8397, 2014. ,
DOI : 10.1111/bpa.12099
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica, Clinica Chimica Acta, vol.415, p.35060, 2013. ,
DOI : 10.1016/j.cca.2012.04.027
The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes, Journal of Autoimmunity, vol.34, issue.4, p.3719, 2010. ,
DOI : 10.1016/j.jaut.2009.09.013
Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler Houndmills Basingstoke Engl, p.5719, 2009. ,
HLA-DRB1 typing in Caucasians patients with neuromyelitis optica], Rev Neurol. 1 août, vol.53, issue.3, p.14652, 2011. ,
Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population, Multiple Sclerosis Journal, vol.189, issue.1, p.2431, 2011. ,
DOI : 10.1371/journal.pgen.0030150
NMO-IgG predicts the outcome of recurrent optic neuritis, Neurology, vol.70, issue.23, p.2197200, 2008. ,
DOI : 10.1212/01.wnl.0000303817.82134.da
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo, Annals of Neurology, vol.66, issue.5, p.63043, 2009. ,
DOI : 10.1002/ana.21837
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury, Brain, vol.133, issue.9, p.257891, 2010. ,
DOI : 10.1093/brain/awq177
Immunology of neuromyelitis optica: a T cell-B cell collaboration, Annals of the New York Academy of Sciences, vol.70, issue.1, p.5766, 2013. ,
DOI : 10.1111/nyas.12118
Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis, Arquivos de Neuro-Psiquiatria, vol.72, issue.6, p.44550, 2014. ,
DOI : 10.1590/0004-282X20140032
Neuromyelitis Optica and Non???Organ-Specific Autoimmunity, Archives of Neurology, vol.65, issue.1, p.7883, 2008. ,
DOI : 10.1001/archneurol.2007.17
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, The Lancet, vol.364, issue.9451, p.210612, 2004. ,
DOI : 10.1016/S0140-6736(04)17551-X
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays, Neurology, vol.78, issue.9, p.665671, 2012. ,
DOI : 10.1212/WNL.0b013e318248dec1
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity, Neurology, vol.80, issue.24, p.2194200, 2013. ,
DOI : 10.1212/WNL.0b013e318296e917
AQP4 autoantibody assay performance in clinical laboratory service, Neurology - Neuroimmunology Neuroinflammation, vol.1, issue.1, p.11, 2014. ,
DOI : 10.1212/NXI.0000000000000011
Brain Involvement in Neuromyelitis Optica Spectrum Disorders, Archives of Neurology, vol.68, issue.11, p.14329, 2011. ,
DOI : 10.1001/archneurol.2011.249
Brain Abnormalities in Neuromyelitis Optica, Archives of Neurology, vol.63, issue.3, p.3906, 2006. ,
DOI : 10.1001/archneur.63.3.390
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression, Archives of Neurology, vol.63, issue.7, p.9648, 2006. ,
DOI : 10.1001/archneur.63.7.964
MRI characteristics of neuromyelitis optica spectrum disorder: An international update, Neurology, vol.84, issue.11, p.116573, 2015. ,
DOI : 10.1212/WNL.0000000000001367
Revised diagnostic criteria for neuromyelitis optica, American Journal of Ophthalmology, vol.142, issue.4, p.14859, 2006. ,
DOI : 10.1016/j.ajo.2006.08.010
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders, Neurology, vol.72, issue.8, p.7127, 2009. ,
DOI : 10.1212/01.wnl.0000343001.36493.ae
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, vol.85, issue.2, p.17789, 2015. ,
DOI : 10.1212/WNL.0000000000001729
Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis, Arquivos de Neuro-Psiquiatria, vol.72, issue.6, p.44550, 2014. ,
DOI : 10.1590/0004-282X20140032
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS), J Neurol. janv, vol.261, issue.1, p.116, 2014. ,
Aquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis, JAMA Neurology, vol.71, issue.1, p.4854, 2014. ,
DOI : 10.1001/jamaneurol.2013.5055
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica, JAMA Neurology, vol.71, issue.3, p.32430, 2014. ,
DOI : 10.1001/jamaneurol.2013.5699
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica, Journal of Clinical Investigation, vol.123, issue.5, p.230616, 2013. ,
DOI : 10.1172/JCI67554
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study, The Lancet Neurology, vol.12, issue.6, p.55462, 2013. ,
DOI : 10.1016/S1474-4422(13)70076-0
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders, Neurotherapeutics, vol.84, issue.1, p.7083, 2016. ,
DOI : 10.1007/s00415-015-7952-8
NMO-IgG: A Specific Biomarker for Neuromyelitis Optica, Disease Markers, vol.22, issue.4, p.197206, 2006. ,
DOI : 10.1155/2006/586306
Short Myelitis Lesions in Aquaporin-4-IgG???Positive Neuromyelitis Optica Spectrum Disorders, JAMA Neurology, vol.72, issue.1, p.817, 2015. ,
DOI : 10.1001/jamaneurol.2014.2137
The Natural History of Recurrent Optic Neuritis, Archives of Neurology, vol.61, issue.9, p.14015, 2004. ,
DOI : 10.1001/archneur.61.9.1401
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination, Autoimmunity Reviews, vol.15, issue.4, 2015. ,
DOI : 10.1016/j.autrev.2015.12.004
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica, Muscle & Nerve, vol.66, issue.1, p.8790, 2009. ,
DOI : 10.1002/mus.21197
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica, Neurology, vol.81, issue.14, p.1197204, 2013. ,
DOI : 10.1212/WNL.0b013e3182a6cb5c
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis, Multiple Sclerosis Journal, vol.22, issue.4, 2015. ,
DOI : 10.1186/2051-5960-2-35
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, Neurology, vol.82, issue.6, p.47481, 2014. ,
DOI : 10.1212/WNL.0000000000000101
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?, Neurology - Neuroimmunology Neuroinflammation, vol.2, issue.1, p.62, 2015. ,
DOI : 10.1212/NXI.0000000000000062
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS, Neurology - Neuroimmunology Neuroinflammation, vol.2, issue.6, p.163, 2015. ,
DOI : 10.1212/NXI.0000000000000163
Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels, Journal of Clinical Neuroscience, vol.18, issue.7, p.9978, 2011. ,
DOI : 10.1016/j.jocn.2010.12.011
Clinical utility of testing AQP4-IgG in CSF, Neurology - Neuroimmunology Neuroinflammation, vol.3, issue.3, p.231, 2016. ,
DOI : 10.1212/NXI.0000000000000231